These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7567130)

  • 1. [Penetration of ceftriaxone (1 or 2 gr intravenous) into mediastinal and cardiac tissues in man].
    Viviand X; Alaya M; Lokiec F; Ennabli K; Said R; Pecking M; Martin C
    Pathol Biol (Paris); 1995 Apr; 43(4):364-9. PubMed ID: 7567130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.
    Martin C; Viviand X; Alaya M; Lokiec F; Ennabli K; Said R; Pecking M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):812-5. PubMed ID: 8851621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Penetration of vancomycin in cardiac and mediastinal tissues in humans].
    Martin C; Alaya M; Mallet MN; Viviand X; Ennabli K; Said R; de Micco P
    Pathol Biol (Paris); 1994 May; 42(5):520-4. PubMed ID: 7824325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perioperative preventive antibiotic treatment with fosfomycin in heart surgery: serum kinetics in extracorporeal circulation and determination of concentration in heart valve tissue].
    Hirt SW; Alken A; Müller H; Haverich A; Vömel W
    Z Kardiol; 1990 Sep; 79(9):615-20. PubMed ID: 2238772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of plasma and cardiac tissue concentrations of ceftriaxone (Rocephin) in open heart surgery.
    Faragó E; Szécsi J; Péterffy A; Mihóczy L
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):358-61. PubMed ID: 2777425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of vancomycin into mediastinal and cardiac tissues in humans.
    Martin C; Alaya M; Mallet MN; Viviand X; Ennabli K; Said R; De Micco P
    Antimicrob Agents Chemother; 1994 Feb; 38(2):396-9. PubMed ID: 8192475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Jehl F; Burtin P; Dopff C; Pinelli G; Villemot JP; Monteil H; Dureux JB
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2493-6. PubMed ID: 1489193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Voiriot P; Dopff C; Scholl H; Clavey M; Villemot JP; Canton P; Dureux JB
    Antimicrob Agents Chemother; 1990 Mar; 34(3):398-401. PubMed ID: 2185690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic use of cefpiramide (CPM) in open heart surgery].
    Koga M; Fukuda S; Moriyama Y; Takenaka K; Iguro Y; Morishita Y; Taira A
    Kyobu Geka; 1989 Nov; 42(12):991-4. PubMed ID: 2593411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma and tissue concentration of ceftriaxone following a one-time i.v. dose of 2 g].
    Küttel JC; Petropoulos P; Crevoisier C
    Schweiz Med Wochenschr; 1988 May; 118(20):786-8. PubMed ID: 3387979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime for prophylaxis of infections in the surgery of cholelithiasis. Results of a multicentric comparative trial.
    Del Rio P; Vellone M; Fragapane P; di Millo M; Mazzitelli R; Allegri C; Nuzzo G; Sianesi M
    Acta Biomed; 2008 Apr; 79(1):23-7. PubMed ID: 18551818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intravitreal penetration of ceftriaxone in man following systemic administration.
    Sharir M; Triester G; Kneer J; Rubinstein E
    Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2179-83. PubMed ID: 2793358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early results of surgical treatment in acquired heart diseases during endocarditis in own material].
    Samitowski Z; Plicner D; Drwiła R; Pietrzyk E; Kopacz J; Kapelak B; Sadowski J
    Przegl Lek; 2004; 61(6):623-6. PubMed ID: 15724650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary and tonsillar distribution of ceftriaxone and cefonicid and the resultant bactericidal activity of the organ].
    Fraschini F; Scaglione F
    Recenti Prog Med; 1990 Jan; 81(1):41-6. PubMed ID: 2236826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):345-52. PubMed ID: 17610408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.